... of anticoagulant treatment on the survival of patients with cancer. The available data show that low-molecular-weight heparins (LMWHs) tend to be more effective and safer than vitamin K antagonists (VKA) in improving survival in patients with cancer. The beneficial effect of anticoagulation with either LMWHs...

.... Protein C deficiency Protein C concentrate Vitamin K antagonists Original Paper Pathophysiol Haemost Thromb 2007 08;36:53 57 DOI: 10.1159/000173721 Received: January 22, 2008 Accepted after revision: February 15, 2008 Successful Protein C Concentrate Administration during Initiation of Oral...

...Sam Schulman Studies have shown that in most patients with venous thromboembolism (VTE), continuation of treatment with vitamin K antagonists for up to 27 months significantly reduces the probability of recurrence. Likewise, prolongation of oral anticoagulation beyond 6 months is believed...

... Vitamin K antagonists Low-molecular-weight heparin Recurrent venous thromboembolism Bleeding Workshop 2 Chairmen: H. Büller, S. Schulman Optimization of Treatment for Venous Thromboembolism and Prevention of Recurrences Haemostasis 1999;29(suppl 1):91 97 Should Patients with Venous Thromboembolism...

... and the International Standardized Index (ISI) for achieving greater consistency of results using different thromboplastins have made it possible to compare the results of vitamin K antagonist drug therapy that was impossible before the introduction of the INR and ISI. However, INR values obtained from the same patient...